
Home » Abiraterone Tx Boosts Survival in Prostate Cancer
Abiraterone Tx Boosts Survival in Prostate Cancer
September 18, 2012
Final results of a phase III trial confirm that treatment with abiraterone prolongs overall survival in metastatic castration-resistant prostate cancer that has progressed after docetaxel therapy.
MedPage Today
MedPage Today
Upcoming Events
-
26Jan
-
27Jan
-
27Jan
-
09Feb
-
10Feb
-
11Feb